irinotecan has been researched along with Tumour Lysis Syndrome in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, EY; Corless, CL; Deloughery, TG; Kearney, MR; Lopez, CD; Stenzel, P; Zivney, M | 1 |
Atasoy, A; Babacan, NA; Cihan, S; Kos, TF; Yildirim, Y | 1 |
Hentrich, M; Hoffmann, U; Lutz, L; Reitmeier, M; Scheidt, B; Schiel, X | 1 |
Boisseau, M; Bugat, R; Mahjoubi, M | 1 |
Crawford, J; Garst, J; Persons, DA; Vollmer, R | 1 |
Inai, K; Kishi, S; Morinaga, K; Naiki, H; Tsutani, H; Ueda, T | 1 |
1 review(s) available for irinotecan and Tumour Lysis Syndrome
Article | Year |
---|---|
Colorectal Cancer-Associated Spontaneous Tumor Lysis Syndrome: a Case Report and Review of the Current Literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Colon, Sigmoid; Colonoscopy; Fatal Outcome; Female; Humans; Irinotecan; Liver; Liver Neoplasms; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Sigmoid Neoplasms; Time Factors; Tomography, X-Ray Computed; Tumor Lysis Syndrome | 2019 |
5 other study(ies) available for irinotecan and Tumour Lysis Syndrome
Article | Year |
---|---|
Hypersensitivity and tumor lysis syndrome associated with cetuximab treatment: should we be afraid?
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Neoplasms; Camptothecin; Cetuximab; Colorectal Neoplasms; Drug Hypersensitivity; Emergency Treatment; Humans; Irinotecan; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome; Tumor Lysis Syndrome | 2015 |
Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Fatal Outcome; Fluorouracil; Humans; Irinotecan; Leucovorin; Lung Neoplasms; Male; Middle Aged; Tumor Lysis Syndrome | 2008 |
Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment (CPT-11)
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Camptothecin; Colonic Neoplasms; Fatal Outcome; Female; Humans; Irinotecan; Tumor Lysis Syndrome | 1996 |
Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin.
Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Humans; Irinotecan; Lung Neoplasms; Tumor Lysis Syndrome | 1998 |
Hepatic tumor rupture following effectual treatment with irinotecan in a patient with highly refractory malignant lymphoma.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Fatal Outcome; Humans; Irinotecan; Liver; Liver Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Rupture; Tumor Lysis Syndrome | 1999 |